Imperial Valley News Center
- Written by Peter Dizikes
Cambridge, Massachusetts - Pharmaceutical firms “underinvest” in long-term research to develop new cancer-fighting drugs due to the greater time and cost required to conduct such research, according to a newly published study co-authored by MIT economists.
- Written by David L. Chandler
Cambridge, Massachusetts - MIT is a key player in a new $600 million public-private partnership announced today by the Obama administration to help strengthen high-tech U.S.-based manufacturing.
- Written by Kevin Leonardi
Cambridge, Massachusetts - Medical devices designed to reside in the stomach have a variety of applications, including prolonged drug delivery, electronic monitoring, and weight-loss intervention. However, these devices, often created with nondegradable elastic polymers, bear an inherent risk of intestinal obstruction as a result of accidental fracture or migration. As such, they are usually designed to remain in the stomach for a limited time.
- Written by Jennifer Chu
Cambridge, Massachusetts - All around the deserts of Utah, Nevada, southern Oregon, and eastern California, ancient shorelines line the hillsides above dry valley floors, like bathtub rings - remnants of the lakes once found throughout the region. Even as the ice sheets retreated at the end of the last ice age, 12,000 years ago, the region remained much wetter than it is today. The earliest settlers of the region are likely to have encountered a verdant landscape of springs and wetlands.
- Written by Robin A. Smith
Durham, North Carolina - The light-sensing molecules that tell plants whether to germinate, when to flower and which direction to grow were inherited millions of years ago from ancient algae, finds a new study from Duke University.
- Written by Bonnie Ward
San Diego, California - A new study by researchers at University of California, San Diego School of Medicine reveals a protein’s critical – and previously unknown - role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer. The finding offers a novel target for better treating AML, and possibly other cancers, by cutting off the ability of tumors to access nearby cellular players that feed its growth.
Page 2877 of 3625